Kylie Michele Bromley
Kylie Michele Bromley was appointed in a total of 7 companies and resigned from 0 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
Australian
Date of Birth
March 1975
Occupation
Unreported
Active
7
Resigned
0
Dissolved
0
Other
0
Total
7
Companies
| Company | Timeline | Status | |
| The Association Of The British Pharmaceutical Industry Director • Unreported | 27 Apr 2024←1 Year 6 Months→Current | Active | |
| Reata UK Limited Director • Unreported | 18 Oct 2023←2 Years 1 Month→Current | Active | |
| Convergence Pharmaceuticals Limited Director • Unreported | 1 Jul 2022←3 Years→Current | Active | |
| Silver Acquisition Co Limited Director • Unreported | 1 Jul 2022←3 Years→Current | Active | |
| Convergence Pharmaceuticals Holdings Limited Director • Unreported | 1 Jul 2022←3 Years→Current | Active | |
| OLD Convergence Pharmaceuticals Limited Director • Unreported | 1 Jul 2022←3 Years→Current | Active | |
| Biogen Idec Limited Director • Unreported | 1 Jul 2022←3 Years→Current | Active | |
Mutual People
- Amit Singh PurwahaBiogen Idec Limited, Silver Acquisition Co Limited, Convergence Pharmaceuticals Holdings Limited, and 3 more are mutual companies.
- Mr Trevor Anthony MillOLD Convergence Pharmaceuticals Limited, Biogen Idec Limited, Convergence Pharmaceuticals Holdings Limited, and 2 more are mutual companies.
- Lori Elizabeth MochanBiogen Idec Limited, Convergence Pharmaceuticals Limited, Silver Acquisition Co Limited, and 2 more are mutual companies.
- Alexandra Isabella HandrichConvergence Pharmaceuticals Holdings Limited, OLD Convergence Pharmaceuticals Limited, Convergence Pharmaceuticals Limited, and 2 more are mutual companies.
- Ms Lori Elizabeth MochanSilver Acquisition Co Limited, OLD Convergence Pharmaceuticals Limited, Biogen Idec Limited, and 2 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
